ArticleVaccines2022

Specific T-Cell Immune Response to SARS-CoV-2 Spike Protein over Time in Naïve and SARS-CoV-2 Previously Infected Subjects Vaccinated with BTN162b2.

Natali Vega-Magaña et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.